Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kyowa Chemical Industry is a Japanese specialty chemical and pharmaceutical company specializing in the development and manufacture of magnesium-based compounds and synthetic hydrotalcites. The company is a global leader in the production of magnesium oxide and magnesium hydroxide, which are utilized as active pharmaceutical ingredients (APIs) for antacids and laxatives, as well as functional excipients. Their flagship pharmaceutical product, Magmit (magnesium oxide), is widely prescribed for the treatment of constipation and gastric acid-related disorders. Beyond healthcare, the company serves various industrial sectors, including plastics and environmental protection, through its high-purity inorganic materials. The company is also recognized for being the first in the world to successfully synthesize hydrotalcite on an industrial scale.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kyowa Chemical Industry.